Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Hypertrophic Olivary Degeneration
Myoclonus · Exhibit Hall C
- 1:15pm-2:45pm
-
Identification of a trehalose treatment regimen with potential to be translated into a therapeutic for the treatment of Parkinson’s disease
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Impaired cerebellum to motor cortex associative plasticity in patients with spinocerebellar ataxia type 3
Neurophysiology (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
Impaired Color Vision in Patients with DLB or Prodromal DLB.
Cognitive Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Implicit memory analysis in patients with Parkinson’s Disease with Deep Brain Stimulation, in ON and OFF stages, using a computerized test battery.
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Improved diagnosis of dementia with Lewy bodies by the combination of Tc-99m ECD SPECT with eZIS analysis and quantitative TRODAT-1 SPECT images
Neuroimaging (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
Impulse Control Disorders in Parkinson’s Disease: Prevalence and Clinical Features in the Rush University Movement Disorders Clinic
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome
Neuroimaging (Non-PD) · Exhibit Hall C
- «Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 38
- Next Page»